Trial
NCT03649321
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Triligent International; Translational Genomics Research Institute; BerGenBio ASA
Condition
Cancer of Pancreas
Intervention
Bemcentinib
Why stopped
Funding was terminated early because research interests were going in a different direction.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-09